TY - JOUR T1 - The pharmacological profile of a novel highly potent bisphosphonate, OX14 (1-fluoro-2-(imidazo-[1,2 alpha]pyridin-3-yl)ethyl-bisphosphonate), with reduced bone affinity, which is as effective as zoledronate in the treatment of myeloma bone disease in JJN3-NOD/SCID-[gamma] mice JO - Bone Abstracts PY - 2016/04/21 AU - Lawson M AU - Chantry A AU - Paton-Hough J AU - Evans H AU - Lath D AU - Tsoumpra M AU - Lundy M AU - Dobson R AU - Quijano M AU - Kwaasi A AU - Dunford J et al ED - DO - DOI: 10.1530/boneabs.5.p128 PB - Bioscientifica Y2 - 2025/05/14 ER -